Last updated on February 2020

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

Brief description of study

The purpose of this multi-center event-driven study in non-dialysis (ND) participants with anemia associated with chronic kidney disease (CKD) is to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa.

Clinical Study Identifier: NCT02876835

Find a site near you

Start Over

GSK Investigational Site

Reservoir, Australia
  Connect »

GSK Investigational Site

Melbourne, Australia
  Connect »